
Individual Medical Procedures (in German “Medizinische Einzelleistungen, MEL”) are medical interventions reimbursed under the catalogue of services maintained by the Ministry of Health (BMASGPK). They include surgical procedures, non-surgical treatments and diagnostic investigations provided during a hospital stay. New medical interventions may be proposed to the MoH for inclusion in the catalogue of services.
The AIHTA is responsible for systematically assessing the comparative effectiveness and safety of these new interventions. Topics are prioritised by a working group of the Federal Health Agency, comprising representatives of the Ministry (BMASGPK), the States (Bundesländer) and the social insurance institutions. The assessment is based on systematic reviews and a presentation of the evidence according to the GRADE framework.
Evaluation of Individual Medical Procedures - Reports
- DSD 148: Transarterial periarticular embolisation (TAPE) for knee and shoulder osteoarthritis
- DSD 147: Pharyngeal electrical stimulation for neurogenic oropharyngeal dysphagia
- Update / DSD 119/ 1. Update: Implantation of a wireless pulmonary artery pressure sensor in patients with advanced heart failure
- DSD 146: Einzeitiger Matrix-assistierter Knorpelersatz mit und ohne Knochenmarkaspiratkonzentrat im Knie
- DSD 145: Thermoablation bei Brustkrebs im Frühstadium: Kryoablation, Mikrowellen, Radiofrequenz, hochintensiver fokussierter Ultraschall und Laserablation
- DSD 144: Medikamentenbeschichteter Ballonkatheter zur Behandlung der Harnröhrenstriktur
- DSD 143: Inselzelltransplantation bei Pankreatektomie, Typ-1-Diabetes mit schweren Hypoglykämien und Nierentransplantation
- Update / DSD 129: Temporäre Nitinol-Implantation (TIND) bei gutartiger Prostatavergrößerung
- Update / DSD 97: Sondenlose Herzschrittmacher. 3. Update 2025
- DSD 141: Thermoablation von benignen Schilddrüsenknoten
- DSD 140: Elektrokonvulsionstherapie bei therapieresistenter Depression und therapieresistenter Schizophrenie
- DSD 139: Perkutane transfemorale heterotope Trikuspidalklappenersatz (CAVI) bei Trikuspidalinsuffizienz
- Update / DSD 45/2. Update 2024: Perkutane renale Denervation bei therapieresistenter Hypertonie
- Update / DSD 24/3. Update 2024: Perkutane transluminale koronare Angioplastie (PTCA) mit drug-eluting balloon (DEB)
- DSD 138: Elektrische aurikuläre Vagus Nervenstimulation bei Schmerzen
- DSD 137: Bleomycin-Elektrosklerotherapie bei Vaskulären Anomalien: Systematische Übersichtsarbeit
- DSD 136: Transkranielle Magnetresonanz-gesteuerte hochintensive fokussierte Ultraschallbehandlung bei Patient*innen mit medikamentenresistentem essentiellen Tremor
- DSD 135: Perkutane Aspirationsthrombektomie bei Lungenembolie
- Update / DSD 118/1. Update 2023: 177Lu-PSMA-Radioligandentherapie bei Patienten mit metastasiertem kastrationsresistentem Prostatakrebs: Systematische Übersichtsarbeit
- Update / DSD 111/1. Update 2023: Allogene mesenchymale Stammzellen bei PatientInnen mit Morbus Crohn-assoziierten, komplexen, perianalen Fisteln
- Update / DSD 41/2. Update 2023: Perkutane Mitralklappenintervention mittels Mitralclip bei Mitralklappeninsuffizienz
- DSD 134: Laparoskopische Reflux-Management-Verfahren für den unteren Ösophagussphinkter (UÖS) bei Patient*innen mit GERD
- DSD 133: Chemosaturation mit perkutaner Leberperfusion für Patient*innen mit Leberkrebs
- DSD 132: His-bundle-pacing zur Stimulation des kardialen Reizleitungssystems
- DSD 131: Mikrowellenablation bei Lebertumoren
- DSD 130: Lebervenen- und Pfortaderembolisation vor einer Major-Leberresektion
- Update / DSD 121: Perkutane transvaskuläre Implantation eines Stents zur Verengung des Koronarsinus
- Update / DSD 109: Subcutaneous implantable cardioverter-defibrillator (S-ICD)
- Update / DSD 100: Stimulation der oberen Atemwege bei mittelschwerer bis schwerer Schlafapnoe
Stellungnahme von Inspire Medical Systems, Inc.
Antwort des AIHTA - Update / DSD 74: Zytoreduktive Chirurgie und hypertherme intraperitoneale Chemotherapie bei sekundärer Peritonealkarzinose
(Master Arbeit / nicht im Auftrag des BMSGPK erstellt) - Update / DSD 64: Perkutane koronare Interventionen (PCI) bei chronischen Komplettverschlüssen (CTO)
- DSD 129: Comparative effectiveness of surgical techniques and devices for the treatment of benign prostatic hyperplasia
- DSD 128: Allogenic bone screw Shark Screw® in patients with hallux valgus or scaphoid fractures/pseudarthroses
- DSD 127: Endoscopic plication therapy in patients with gastroesophageal reflux disease (GERD)
- DSD 126: Triphasic biomaterial for augmentation of the osteoporotic femoral neck
- DSD 125: Liposuction for surgical therapy of lipoedema
- DSD 124: Percutaneous left ventricular assist devices: micro-axial flow pumps
- Update / DSD 87/1. Update 2021: Implantation of Bulking Agents for Faecal Incontinence
- DSD 123: Vaskuläre photodynamische Therapie mit Padeliporfin (Tookad® Lösung)
- DSD 122: Radiofrequency-Induced Intravesical Chemohyperthermia for Non-Muscle-Invasive Bladder Cancerm
- DSD 121: Percutaneous Transvascular Implantation of a Coronary Sinus Reducing Stent
- DSD 120: Intrauterine ultrasound-guided transcervical radiofrequency ablation
- DSD 119: Implantation of a wireless pulmonary artery pressure sensor in patients with advanced heart failure’
- Update / DSD 106/Update 2020: Extracorporeal cytokine haemadsorption therapy in patients with sepsis or SIRS
- Update / DSD 97/2. Update 2020: Leadless pacemaker for right ventricle pacing
- DSD 118: 177Lu-PSMA Therapy in Patients with Metastatic Castration-Resistant Prostate Cancer
- DSD 117: Human dermal allograft for massive rotator cuff tears
- DSD 116: Allograft for anterior and posterior cruciate ligament reconstruction
- DSD 115: Osteochondral allograft transplantation for the knee (or other joints)
- Update / DSD 100/1. Update 2019: Upper Airway Stimulation for Moderate-to-Severe Sleep Apnea
- Update / DSD 99/1. Update 2019: Radiofrequency denervation for lumbar and cervical facet joint pain – a systematic review
- Update / DSD 98/1. Update 2019: Single-/two-step scaffold-based cartilage repair in the knee and ankle joint
- Update / DSD 65/1. Update 2019: Annulus Fibrosus Repair after lumbar discectom
- DSD 113: Baroreceptor activation therapy for treatment-resitant hypertension
- DSD 112: Meniscal allograft transplantation
- DSD 111: Allogeneic mesenchymal stem cells for Crohn’s disease-associated complex perianal fistulas
- DSD 110: Lymphovenous anastomoses in patients with primary and secondary lymphedema
- DSD 109: Subcutaneous implantable cardioverter defibrillator (ICD)
- Update / DSD 44/3. Update 2018: Left Atrial Appendage Closure for the prevention of thrombo-embolic events in patients with atrial fibrillation
- Update / DSD 37/1.Update 2018: High intensity focused ultrasound (HIFU) for the treatment of prostate cancer
- Update / DSD 20//4. Update 2018: Endobronchial valve implantation for emphysema
- DSD 108: Radiofrequency ablation for metastatic spinal lesions
- DSD 107: Repetitive transcranial magnetic stimulation for treatment-resistant major depression
- DSD 106: Extracorporeal cytokine haemadsorption therapy in patients with sepsis or SIRS
- DSD 105: Prostate artery embolisation for benign prostatic hyperplasia
- DSD 104: Electric stimulation therapy (EST) in patients with gastroesophageal reflux disease (GERD)
- Update / DSD 97/Update 2017: Leadless pacemakers for right ventricle pacing
- Update / DSD 21/Update 2017: Percutaneous disc volume reduction – chemonucleolysis
- DSD 101: Magnetic sphincter augmentation device (MSAD) in patients with gastroesophageal reflux disease (GERD)
- DSD 100: Upper airway stimulation for moderate-to-severe sleep apnea
- DSD 99: Radiofrequency denervation for sacroiliac and facet joint pain
- DSD 98: Single-step scaffold-based cartilage repair in the knee
- DSD 97: Leadless pacemakers for right ventricle pacin
- Update / DSD 24/Update 2016: Percutaneous transluminal coronary angioplasty (PTCA) with drug-eluting balloon (DEB)
- DSD 87: Injectable bulking agents for faecal incontinence
- DSD 86: Sphenopalatine Ganglion (SPG) stimulation of patients with therapy-resistant cluster headache
- DSD 85: Intrastromal corneal implants for ectatic corneal disorders
- DSD 84: Defibrotide for the treatment and prophylaxis of hepatic veno-occlusive disease
- DSD 83: Endovascular embolization of unruptured intracranial aneurysms with flow diverters
- DSD 82: Transcatheter mitral valve-in-valve implantation (TMViVI)
- DSD 81: Fully bioresorbable scaffolds for coronary artery disease
- Update / DSD 68/ 1st Update 2015: Percutaneous transluminal angioplasty (PTA) of periphery arteries with drug-eluting balloon (DEB)
- Update / DSD 44/ 2nd Update 2015: Percutaneous left atrial appendage closure for the prevention of thromboembolic events in patients with atrial fibrillation
- DSD 76: Stereotactic Radiofrequency ablation/ SRFA for hepatocellular carcinoma and liver metastases
- DSD 75: Drug eluting stents for the treatment of peripheral artery disease
- DSD 74: Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy of peritoneal carcinomatosis
- Update / DSD 44/1. Update 2014: Percutaneous left atrial appendage closure for the prevention of thromboembolic events in patients with atrial fibrillation
- Update / DSD 20/ Update 2014: Implantation of endobronchial valves in patients with emphysema
- DSD 71: Percutaneous transluminal septal myocardial ablation (PTSMA) in hypertrophic obstructive cardiomyopathy (HOCM)
- DSD 70: Percutaneous transcatheter closure of prosthetic mitral and aortic paravalvular leaks
- DSD 69: Endovascular repair of aortic aneurysms
- DSD 68: Percutaneous transluminal angioplasty (PTA) of periphery arteries with drug-eluting balloon (DEB)
- DSD 67: Duodeno-jejunal bypass liner (DJBL) for patients with obesity
- DSD 66: Repair of cartilage defects via matrix-asocciated autologous chondrocyte immigration
- DSD 65: Implantation of a lumbar artificial endoprosthesis (anuloplasty/ anular repair device)
- Letter to the editor
- Response to the letter - DSD 64: Percutaneous coronary intervention for chronic total occlusion
- Update / DSD 24/ Update 2013: Percuteneous transluminal coronary angioplasty (PTCA) with paclitaxel-coated drug-eluting balloon (DEB) (1st Update)
- DSD 60: Sling suspension in male urinary incontinence
- DSD 59: Radiofrequency Ablation for Treatment of Tumors of the Urogenital Tract (Renal Cell Carcinoma, Prostate Cancer and Uterine Leiomyoma)
- DSD 58: Radiofrequency ablation of primary tumors of the gastrointestinal tract (colorectal and pancreatic cancer)
- DSD 57: Radiofrequency Ablation for Treatment of Breast Cancer
- DSD 56: Radiofrequency Ablation for Treatment of Benign and Malignant Lesions of Endocrine Organs (Thyroid and Adrenal Gland)
- DSD 55: Radiofrequency Ablation for Treatment of Head and Neck Cancer
- DSD 54: Radiofrequency ablation of bone tumors (osteoid-osteoma and osseous metastases)
- DSD 53: Radiofrequency ablation of tumors of the lung and mediastinal lymph nodes
- Update / DSD 45/ Update 2012: Renal denervation in patients with essential hypertension
- Update / DSD 41/ Update 2012: Percutaneous repair of mitral regurgitation with the MitraClip
- Update / DSD 23/ Update 2012: Intraoperative radiotherapy for primary breast cancer
- Update / DSD 06/ Update 2012: Cell therapy for urinary stress incontinence
- DSD 47: Selective internal radiotherapy using yttrium-90 microspheres for primary and secondary liver malignanciesDSD 43: Vascular-Endothelial-Growth-Factor-Inhibitors (anti-VEGF) in the Management of Diabetic Macular Oedema
DSD 46: Mechanical percutaneous transluminal cerebral clot retrieval devices in acute ischemic stroke: Systematic Review on efficacy and safety - DSD 45: Renal denervation in patients with essential hypertonia
- DSD 44: Percutaneous left atrial appendage closure for the prevention of thromboembolic events in patients with atrial fibrillation
- Update / DSD 18/Update 2011: Percutaneous aortic valve replacement (with a side note to hybrid operating rooms)
- DSD 41: Mitral valve repair using a mitral clip
- DSD 40: Radionuclide therapy - 90Yttrium and 177Lutetium somatostatin analogues for the treatment of inoperable neuroendocrine tumors
- DSD 39: Laser angioplasty of coronary arteries
- DSD 38: Artificial disc replacement
- DSD 37: High intensity focused ultrasound (HIFU) for the treatment of prostate cancer
- Update / DSD 20/ Update 2010: Endobronchial valve implantation for emphysema
- Update / DSD 18/ Update 2010: Percutaneous aortic valve replacement
- Update / DSD 15/ Update 2010: Cardiac contractility modulation for heart failure
- Update / DSD 14/ Addendum 2010: Stent-grafting of the ascending aorta
- Update / DSD 08/ Update 2010: Kyphoplasty and vertebroplasty for osteoporotic vertebral compression fractures
- DSD 30: Retroluminal transobturatoric reposition sling for the treatment of stress urinary incontinence in men
- DSD 27: Pumpless extracorporeal lung assist (PECLA)
- DSD 26: Image guided radiotherapy using cone-beam computed tomography
- DSD 25: Selective IgG Apheresis for ABO-incompatible kidney transplantation
- DSD 24: Drug coated balloon catheter
- DSD 23: Intraoperative radiotherapy for primary breast cancer
- DSD 22: Injection therapies and radiofrequency for the treatment of chronic back pain
- DSD 21b: Percutaneous nucleotomy and percutaneours laser disk decompression
- DSD 21a: Chemonucleolysis and intradiscal electrotherapy (IDET)
- Update / DSD 20/ Update 2009: Endobronchial valve implantation for emphysema- Report not published
- Update / DSD 18/ Update 2009: Percutaneous aortic valve replacement
- Update / DSD 15/ Update 2009: Cardiac contractility modulation for heart failure
- Update / DSD 14/ Update 2009: Stent-grafting of the ascending aorta
- DSD 20: Endobronchial valve implantation for emphysema - Report not published
- DSD 18: Percutaneous aortic valve replacement
- DSD 15: Cardiac contractility modulation for heart failure
- DSD 14: Stent-grafting of the ascending aorta
- DSD 13: Optical Coherence Tomography
- DSD 12: Rheopheresis® in patients with age-related macular degeneration, sudden hearing loss or tinnitus, diabetes
- DSD 11: Selective Cell Apheresis in Inflammatory Bowel Disease
- DSD 10: Percutaneous pulmonary valve implantation for right ventricular outflow tract dysfunction in patients with congenital heart defects
- DSD 8: Kyphoplasty and vertebroplasty for osteoporotic vertebral compression fractures
- DSD 7: LDL apheresis
- DSD 6: New minimally invasive methods in the treatment of stress urinary incontinence